Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 19-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical Products17$195.50  View Abstract
19-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Skystar Bio-Pharmaceutical Company41$471.50  View Abstract
15-Jun-13Pechala's ReportsFrantisek PechalaSKYSTAR BIO-PHARMACEUTICAL CO (SKBI) 12-months forecast1$15  View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (Asia)85$977.50  View Abstract
9-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL (SKBI)5$10  View Abstract
2-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL (SKBI)5$10  View Abstract
26-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10  View Abstract
19-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10  View Abstract
12-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10  View Abstract
5-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10  View Abstract

Independent Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical Products17$195.50View Abstract
19-Jun-13Wright ReportsN/AWright Investors Service Comprehensive Report for Skystar Bio-Pharmaceutical Company41$471.50View Abstract
15-Jun-13Pechala's ReportsFrantisek PechalaSKYSTAR BIO-PHARMACEUTICAL CO (SKBI) 12-months forecast1$15View Abstract
14-Jun-13Wright ReportsN/AWright Industry Averages: Pharmaceuticals & Biotechnology (Asia)85$977.50View Abstract
9-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL (SKBI)5$10View Abstract
2-Jun-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL (SKBI)5$10View Abstract
26-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10View Abstract
19-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10View Abstract
12-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10View Abstract
5-May-13TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SKYSTAR BIO-PHARMACEUTICAL5$10View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.